Bio equivalence of Two Subcutaneous Pharmaceutical Products of Interferon Beta la
Guillermo Di Girolamo(Universidad de Buenos Aires), Roberto A. Díez(Universidad de Buenos Aires), Mariana Papouchado(Sab Biotherapeutics (United States)), Marcelo Kauffman(Hospital Ramos Mejía), Eliseo González(Centro Diagnostico Italiano), Alejandra Catalina Muñoz Ramírez(Sab Biotherapeutics (United States)), Susana Dabsys(Sab Biotherapeutics (United States)), A. M. Vidal, César Carbonetto(Sab Biotherapeutics (United States)), Aída Sterin‐Prync(Sab Biotherapeutics (United States)), Guillermo Alberto Keller(Universidad de Buenos Aires)
Cited by 7
Related Papers
The Phagosome Proteome
|The Journal of Cell Biology|2001|692
RACK1 Competes with HSP90 for Binding to HIF-1α and Is Required for O2-Independent and HSP90 Inhibitor-Induced Degradation of HIF-1α
|Molecular Cell|2007|470
Rab5 regulates the kiss and run fusion between phagosomes and endosomes and the acquisition of phagosome leishmanicidal properties in RAW 264.7 macrophages
|Journal of Cell Science|2000|179
Cytokines in adenoviral disease in children: Association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome
|The Journal of Pediatrics|1994|147
Pre- and Post-Treatment Serum Levels of Cytokines IL-1β, IL-6, and IL-1 Receptor Antagonist in Celiac Disease. Are They Related to the Associated Osteopenia?
|The American Journal of Gastroenterology|1998|146